(Q30451742)

14 September 2017

Intranasal recombinant alfa-2b interferon treatment of naturally occurring common colds (English)

1 reference

14 September 2017

Hayden FG

1

1 reference

14 September 2017

Kaiser DL

series ordinal

2

1 reference

14 September 2017

Albrecht JK

series ordinal

3

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 February 1988

1 reference

Antimicrobial Agents and Chemotherapy

14 September 2017

1 reference

14 September 2017

32

1 reference

14 September 2017

224-230

1 reference

14 September 2017

2

1 reference

Automated, quantitative cytopathic effect reduction assay for interferon

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172139

Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172139

Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172139

Intranasal interferon-alpha 2 prophylaxis of natural respiratory virus infection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172139

Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon

20 June 2018

1 reference

12 December 2020

Intranasal interferon-alpha 2b for seasonal prophylaxis of respiratory infection

1 reference

12 December 2020

Human nasal mucosal responses to topically applied recombinant leukocyte A interferon

1 reference

12 December 2020

Upper respiratory tract viral infection and mucociliary clearance

1 reference

12 December 2020

Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli

1 reference

12 December 2020

Anti-interferon antibody increases rhinovirus isolation rates from nasal wash specimens containing interferon-alpha2

1 reference

12 December 2020

Intranasal Interferon 2 for Prevention of Rhinovirus Infection and Illness

1 reference

12 December 2020

Human Tolerance and Histopathologic Effects of Long-Term Administration of Intranasal Interferon- 2

1 reference

12 December 2020

Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds

1 reference

12 December 2020

Antibody to human leucocyte interferon may enhance the frequency of rhinovirus isolation

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.32.2.224

1 reference

14 September 2017

1 reference

14 September 2017

1 reference